Trgovina TransCode Therapeutics, Inc. - RNAZ CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.07 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 3.15 |
Odpri* | 3.25 |
Enoletna sprememba* | 86.78% |
Dnevni razpon* | 3 - 3.3 |
Razpon 52 wk | 3.12-42.00 |
Povprečni obseg (10 dni) | 581.63K |
Povprečni obseg (3 meseci) | 2.57M |
Tržna kapitalizacija | 2.73M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 849.93K |
Prihodki | N/A |
EPS | -1.42 |
Dividenda (donosnost v %) | N/A |
Beta | -100.00K |
Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 7, 2023 | 3.03 | -0.35 | -10.36% | 3.38 | 3.42 | 2.99 |
Jun 6, 2023 | 3.13 | -0.60 | -16.09% | 3.73 | 3.73 | 3.04 |
Jun 5, 2023 | 3.98 | 0.04 | 1.02% | 3.94 | 4.03 | 3.87 |
Jun 2, 2023 | 3.88 | -0.31 | -7.40% | 4.19 | 5.52 | 3.88 |
Jun 1, 2023 | 4.05 | -0.01 | -0.25% | 4.06 | 4.15 | 3.70 |
May 31, 2023 | 4.18 | -0.40 | -8.73% | 4.58 | 4.58 | 4.08 |
May 30, 2023 | 4.64 | -0.23 | -4.72% | 4.87 | 4.88 | 4.40 |
May 26, 2023 | 4.86 | -0.16 | -3.19% | 5.02 | 5.02 | 4.84 |
May 25, 2023 | 4.79 | -0.78 | -14.00% | 5.57 | 5.57 | 4.70 |
May 24, 2023 | 5.58 | -0.39 | -6.53% | 5.97 | 5.97 | 5.46 |
May 23, 2023 | 5.99 | 0.79 | 15.19% | 5.20 | 7.47 | 5.19 |
Apr 27, 2023 | 0.39 | -0.02 | -4.88% | 0.41 | 0.42 | 0.39 |
Apr 18, 2023 | 0.39 | 0.01 | 2.63% | 0.38 | 0.39 | 0.38 |
Apr 17, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Apr 13, 2023 | 0.38 | -0.01 | -2.56% | 0.39 | 0.40 | 0.38 |
Apr 11, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Apr 5, 2023 | 0.39 | 0.00 | 0.00% | 0.39 | 0.46 | 0.38 |
Mar 14, 2023 | 0.38 | 0.01 | 2.70% | 0.37 | 0.38 | 0.37 |
Mar 10, 2023 | 0.38 | -0.01 | -2.56% | 0.39 | 0.40 | 0.38 |
Mar 9, 2023 | 0.40 | -0.01 | -2.44% | 0.41 | 0.41 | 0.40 |
TransCode Therapeutics, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 18.6658 | 6.15114 | 0.7266 | 0.45687 | 0.384 |
Celotna prodaja/splošni/upravni stroški Odhodki | 8.43345 | 3.39717 | 0.44215 | 0.23056 | 0.30146 |
Raziskave in razvoj | 10.2324 | 2.75397 | 0.28446 | 0.22631 | 0.08253 |
Prihodki iz poslovanja | -18.6658 | -6.15114 | -0.7266 | -0.45687 | -0.384 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.02041 | -0.96141 | -1.60243 | -0.15294 | -0.07192 |
Drugo, neto | 1.08044 | 0.27222 | -0.01485 | 0.00258 | 0.00248 |
Čisti dobiček pred obdavčitvijo | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Čisti dobiček po davkih | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Čisti dobiček pred dodatnimi postavkami | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Čisti dobiček | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Popravljen čisti dobiček | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Popravljene ponderirane povprečne delnice | 12.9772 | 8.42588 | 8.48508 | 8.48508 | 8.48508 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.35352 | -0.81219 | -0.27624 | -0.07156 | -0.05344 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Popravljen normalizirani dobiček na enoto čistega dobička | -1.35352 | -0.81182 | -0.27624 | -0.07156 | -0.05344 |
Gain (Loss) on Sale of Assets | 0 | -0.00308 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 4.90111 | 5.52746 | 4.95356 | 4.70729 | 3.4775 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2.30976 | 2.84072 | 1.90954 | 2.08727 | 1.59593 |
Raziskave in razvoj | 2.59135 | 2.68674 | 3.04402 | 2.62003 | 1.88158 |
Prihodki iz poslovanja | -4.90111 | -5.52746 | -4.95356 | -4.70729 | -3.4775 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.00477 | 0.00964 | 0.009 | 0.00133 | 0.00044 |
Drugo, neto | 0.07941 | 0.38377 | 0.65495 | 0.03473 | 0.00699 |
Čisti dobiček pred obdavčitvijo | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Čisti dobiček po davkih | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Čisti dobiček pred dodatnimi postavkami | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Čisti dobiček | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Popravljen čisti dobiček | -4.81693 | -5.13406 | -4.28961 | -4.67123 | -3.47007 |
Popravljene ponderirane povprečne delnice | 14.4004 | 12.9772 | 12.9772 | 12.9772 | 12.9772 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.3345 | -0.39562 | -0.33055 | -0.35996 | -0.2674 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.3345 | -0.39562 | -0.33055 | -0.35996 | -0.2674 |
Gain (Loss) on Sale of Assets | 0 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 7.37941 | 22.7322 | 0.83122 | 0.20447 | 0.21465 |
Denarna sredstva in kratkoročne naložbe | 4.97783 | 20.8259 | 0.82802 | 0.20447 | 0.21298 |
Denarna sredstva in ustrezniki | 4.96842 | 20.8259 | 0.82802 | 0.20447 | 0.21298 |
Prepaid Expenses | 2.04135 | 1.90632 | 0.0032 | 0 | 0.00167 |
Total Assets | 7.58799 | 22.9384 | 1.05537 | 0.20447 | 0.21465 |
Total Current Liabilities | 4.34729 | 2.5341 | 0.40486 | 0.06294 | 0.11768 |
Payable/Accrued | 3.42382 | 2.50357 | 0.36918 | 0.02726 | 0.082 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 0.03053 | 0.03569 | 0.03569 | 0.03569 |
Total Liabilities | 4.34729 | 2.5341 | 4.4636 | 1.31425 | 0.71861 |
Total Long Term Debt | 0 | 0 | 2.08668 | 0.92781 | 0.43622 |
Long Term Debt | 0 | 2.08668 | 0.92781 | 0.43622 | |
Other Liabilities, Total | 0 | 1.97206 | 0.3235 | 0.16472 | |
Total Equity | 3.2407 | 20.4044 | -3.40823 | -1.10978 | -0.50397 |
Common Stock | 0.0013 | 0.00129 | 0.00046 | 0.00046 | 0.00076 |
Additional Paid-In Capital | 31.1096 | 30.7083 | 0.05319 | 0.00774 | 0.00605 |
Retained Earnings (Accumulated Deficit) | -27.8703 | -10.3053 | -3.46188 | -1.11799 | -0.51078 |
Total Liabilities & Shareholders’ Equity | 7.58799 | 22.9384 | 1.05537 | 0.20447 | 0.21465 |
Total Common Shares Outstanding | 12.9772 | 12.9046 | 8.48508 | 8.48508 | 8.48508 |
Other Long Term Assets, Total | 0 | 0.22415 | 0 | ||
Property/Plant/Equipment, Total - Net | 0.20858 | 0.20627 | |||
Cash | 0.00941 | ||||
Celotne terjatve, neto | 0.36023 | ||||
Property/Plant/Equipment, Total - Gross | 0.34844 | ||||
Accumulated Depreciation, Total | -0.13986 | ||||
Accrued Expenses | 0.92347 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 4.34662 | 7.37941 | 11.5699 | 13.9208 | 18.6347 |
Denarna sredstva in kratkoročne naložbe | 1.63207 | 4.97783 | 8.79995 | 13.4478 | 16.862 |
Denarna sredstva in ustrezniki | 1.62266 | 4.96842 | 8.79054 | 13.4384 | 16.8526 |
Prepaid Expenses | 2.71456 | 2.04135 | 2.28206 | 0.43826 | 1.77266 |
Total Assets | 5.59051 | 7.58799 | 12.0156 | 14.1555 | 18.85 |
Property/Plant/Equipment, Total - Net | 0.99623 | 0.20858 | 0.20987 | 0.23467 | 0.21532 |
Other Long Term Assets, Total | 0.24765 | 0.23582 | |||
Total Current Liabilities | 5.44949 | 4.34729 | 3.77138 | 1.72725 | 1.84918 |
Payable/Accrued | 3.63739 | 3.42382 | 3.31376 | 1.14011 | 1.4378 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 0.02354 | 0.02354 | 0.02354 | |
Total Liabilities | 5.8273 | 4.34729 | 3.77138 | 1.72725 | 1.84918 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | |||||
Other Liabilities, Total | 0.37781 | ||||
Total Equity | -0.23679 | 3.2407 | 8.2442 | 12.4282 | 17.0008 |
Common Stock | 0.00158 | 0.0013 | 0.0013 | 0.0013 | 0.0013 |
Additional Paid-In Capital | 32.4488 | 31.1096 | 30.9791 | 30.8735 | 30.7749 |
Retained Earnings (Accumulated Deficit) | -32.6872 | -27.8703 | -22.7362 | -18.4466 | -13.7753 |
Total Liabilities & Shareholders’ Equity | 5.59051 | 7.58799 | 12.0156 | 14.1555 | 18.85 |
Total Common Shares Outstanding | 15.8235 | 12.9772 | 12.9772 | 12.9772 | 12.9772 |
Cash | 0.00941 | 0.00941 | 0.00941 | 0.00941 | 0.00941 |
Property/Plant/Equipment, Total - Gross | 0.36134 | 0.34844 | 0.32023 | 0.32023 | 0.27818 |
Accumulated Depreciation, Total | -0.1695 | -0.13986 | -0.11036 | -0.08555 | -0.06286 |
Accrued Expenses | 1.8121 | 0.92347 | 0.43408 | 0.5636 | 0.38784 |
Celotne terjatve, neto | 0 | 0.36023 | 0.48788 | 0.03473 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -17.565 | -6.8434 | -2.34389 | -0.60721 | -0.45344 |
Denarna sredstva iz poslovanja | -15.7625 | -5.26689 | -0.49297 | -0.50851 | -0.29957 |
Nedenarne postavke | 0.3648 | 1.13219 | 1.54116 | 0.10341 | 0.07027 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | |
Denarna sredstva Plačane obresti | 0.03712 | 0.01787 | 0 | 0 | 0 |
Spremembe v obratnem kapitalu | 1.33905 | 0.40186 | 0.30976 | -0.0047 | 0.0836 |
Denarna sredstva pri financiranju | 0.00599 | 25.5166 | 1.11652 | 0.5 | 0.51243 |
Postavke denarnega toka pri financiranju | 0 | -0.83168 | -0.07348 | 0 | -0.04099 |
Izdaja (odplačilo) delnic, neto | 0.00599 | 26.3482 | 0.00342 | ||
Izdaja (odplačilo) dolga, neto | 0 | 1.19 | 0.5 | 0.55 | |
Neto sprememba denarnih sredstev | -15.8574 | 19.9978 | 0.62355 | -0.00851 | 0.21286 |
Denarna sredstva iz poslovanja | 0.09861 | 0.04247 | |||
Denarna sredstva pri naložbenju | -0.10092 | -0.25182 | |||
Kapitalski izdatki | -0.10092 | -0.25482 | |||
Celotne druge postavke denarnih tokov pri naložbenju | 0 | 0.003 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -4.81693 | -17.565 | -12.4309 | -8.1413 | -3.47007 |
Cash From Operating Activities | -4.51355 | -15.7625 | -11.7428 | -7.32076 | -3.94857 |
Cash From Operating Activities | 0.02964 | 0.09861 | 0.0691 | 0.0443 | 0.0216 |
Non-Cash Items | 0.22932 | 0.3648 | 0.25778 | 0.15917 | 0.06057 |
Cash Taxes Paid | 0 | 0 | |||
Changes in Working Capital | 0.04442 | 1.33905 | 0.36124 | 0.61707 | -0.56067 |
Cash From Investing Activities | -0.0129 | -0.10092 | -0.0727 | -0.0727 | -0.03066 |
Capital Expenditures | -0.0129 | -0.10092 | -0.0727 | -0.0727 | -0.03066 |
Cash From Financing Activities | 1.18069 | 0.00599 | -0.21983 | 0.00599 | 0.00599 |
Financing Cash Flow Items | 0 | -0.22582 | 0 | ||
Issuance (Retirement) of Stock, Net | 1.18069 | 0.00599 | 0.00599 | 0.00599 | 0.00599 |
Issuance (Retirement) of Debt, Net | |||||
Net Change in Cash | -3.34576 | -15.8574 | -12.0353 | -7.38748 | -3.97323 |
Other Investing Cash Flow Items, Total | 0 | ||||
Cash Interest Paid | 0.0083 | 0.03712 | 0.02062 | 0.00513 | 0.00443 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
TransCode Therapeutics, Inc. Company profile
O družbi TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. je biofarmacevtsko podjetje, ki se osredotoča na razvoj in trženje zdravil za zdravljenje metastatskih bolezni. Razvila je modularni sistem nanodelcev na osnovi železovih oksidov za dostavo RNA-terapevtikov v tumorje. Vodilni terapevtski kandidat družbe, TTX-MC138, je usmerjen proti mikroRNA-10b (miRNA-10b), glavnemu regulatorju vitalnosti metastatskih celic pri različnih vrstah raka, vključno z rakom dojke, trebušne slinavke, jajčnikov, debelega črevesa, glioblastomi in drugimi. Njegovi predklinični programi vključujejo dva programa za solidne tumorje, kot sta TTX-siPDL1, modulator programirane smrti-liganda 1 (PD-L1) na osnovi majhne interferenčne RNK (siRNA), in TTX-siLin28b, inhibitor RNA-vezavnega proteina LIN28B na osnovi siRNA.
Industry: | Biotechnology & Medical Research (NEC) |
6 Liberty Square
#2382
BOSTON
MASSACHUSETTS 02109
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com